Leading local drugmaker Aristopharma has signed a contract manufacturing deal with market leader Square Pharmaceuticals PLC to produce some products for the latter.

Aristopharma will manufacture some injectable items, tablets and dry syrups for the listed pharmaceuticals company, officials of the two firms told The Daily Star.

The board of directors of Square Pharmaceuticals gave go-ahead to the contract manufacturing agreement on July 12 this year to meet increased demand of its existing products and to introduce new products.

Square Pharmaceuticals shared the information through a posting on the website of the Dhaka Stock Exchange (DSE) today.

Aristopharma is a non-listed company that started its operations in 1986 and has a state-of-the-art manufacturing plant in Dhaka's Shampur-Kadamtali.

Today, stock prices of Square Pharmaceuticals remained almost the same as the previous day and traded at Tk 209 at the DSE.

During July of 2022 to March of 2023, Square's sales grew 10 per cent year-on-year to Tk 4,814 crore.